Reuters: Business News: Salix bolsters gastro drug line-up with $2.6 billion Santarus buy

Reuters: Business News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.

Salix bolsters gastro drug line-up with $2.6 billion Santarus buy Nov 8th 2013, 02:13 (Reuters) - Salix Pharmaceuticals Ltd will buy Santarus Inc for about $2.6 billion, gaining two new gastroenterology drugs to strengthen its leading presence in that market and sending its shares 10 percent higher.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions